Catalyst Pharmaceuticals Inc
(14888U101)
ファンドの報告 Catalyst Pharmaceuticals Inc 13F提出書類による
| 商号 | 保有株式/元本 | 市場価格 | オプション | 報告期間 | 有効日 |
|---|---|---|---|---|---|
| Consonance Capital Management LP | 17,875,655 | $68,643k | Jun 30, 2019 | Aug 14, 2019 | |
| Armistice Capital LLC | 5,000,000 | $19,200k | Jun 30, 2019 | Aug 14, 2019 | |
| Mangrove Partners | 3,837,181 | $14,735k | Jun 30, 2019 | Aug 14, 2019 | |
| Broadfin Capital LLC | 2,765,070 | $10,618k | Jun 30, 2019 | Aug 14, 2019 | |
| Baker BROS Advisors LP | 2,559,461 | $9,828k | Jun 30, 2019 | Aug 14, 2019 | |
| Gables Capital Management Inc | 486,064 | $1,869k | Jun 30, 2019 | Jul 31, 2019 | |
| Brandywine Global Investment Management LLC | 349,072 | $1,341k | Jun 30, 2019 | Aug 14, 2019 | |
| Panagora Asset Management Inc | 297,238 | $1,141k | Jun 30, 2019 | Aug 9, 2019 | |
| Acadian Asset Management LLC | 76,416 | $293k | Jun 30, 2019 | Aug 8, 2019 | |
| Prelude Capital Management LLC | 23,270 | $89k | Jun 30, 2019 | Aug 14, 2019 | |
| Provise Management Group LLC | 19,000 | $73k | Jun 30, 2019 | Aug 9, 2019 | |
| QS Investors LLC | 1,182 | $5k | Jun 30, 2019 | Aug 14, 2019 |